GKB Ophthalmics Limited Share Price

Equities

GKB

INE265D01015

Medical Equipment, Supplies & Distribution

Market Closed - Bombay S.E. 11:10:06 31/05/2024 BST 5-day change 1st Jan Change
93.55 INR -3.11% Intraday chart for GKB Ophthalmics Limited -10.90% -6.51%

Financials

Sales 2022 709M 8.5M 668M Sales 2023 755M 9.05M 710M Capitalization 547M 6.56M 515M
Net income 2022 12M 144K 11.29M Net income 2023 -1M -11.99K -941K EV / Sales 2022 0.6 x
Net cash position 2022 40.6M 487K 38.2M Net cash position 2023 28.99M 348K 27.28M EV / Sales 2023 0.69 x
P/E ratio 2022
36.4 x
P/E ratio 2023
-327 x
Employees 179
Yield 2022 *
-
Yield 2023
-
Free-Float 26.65%
More Fundamentals * Assessed data
Dynamic Chart
GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
GKB Ophthalmics Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
GKB Ophthalmics Limited Announces demises of Sadashiv Shet as Non-Executive independent Director CI
GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
GKB Ophthalmics Limited Announces Unaudited Standalone and Consolidated Earnings Results for the First Quarter Ended June 30, 2021 CI
GKB Ophthalmics Limited Announces Audited Standalone Earnings Results for the Quarter and Year Ended March 31, 2021 CI
GKB Ophthalmics Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2020 CI
More news
1 day-3.11%
1 week-10.90%
1 month-23.56%
3 months+10.38%
6 months-4.06%
Current year-6.51%
More quotes
1 week
91.05
Extreme 91.05
108.00
1 month
91.05
Extreme 91.05
124.70
Current year
74.10
Extreme 74.1
136.40
1 year
74.10
Extreme 74.1
136.40
3 years
63.30
Extreme 63.3
197.90
5 years
28.35
Extreme 28.35
197.90
10 years
28.25
Extreme 28.25
209.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 82 09/12/81
Director of Finance/CFO - 31/03/19
Compliance Officer - 31/03/19
Members of the board TitleAgeSince
Chief Executive Officer 82 09/12/81
Director/Board Member 55 23/07/96
Director/Board Member 66 30/03/15
More insiders
Date Price Change Volume
31/05/24 93.55 -3.11% 10,442
30/05/24 96.55 -5.94% 10,762
29/05/24 102.6 +2.55% 2,814
28/05/24 100.1 -4.67% 7,110
27/05/24 105 -.--% 4,167

Delayed Quote Bombay S.E., May 31, 2024 at 11:10 am

More quotes
GKB Ophthalmics Limited is an India-based company, which is engaged in the business of manufacturing and supplying semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. Its products are exported to various countries across the globe. The Company has manufacturing facilities at Tivim Industrial Estate, Mapusa, Goa. GSV Ophthatmics Private Limited and GKB Ophthalmics Products FZE are its subsidiaries.
More about the company